Category Archives: Neuroscience

How I taught neuroscience to primary pupils – and why – TES News

At the beginning of each academic year, we teach our students about the brain.

When I first encountered this aspect of our curriculum, I doubted its value. Sure enough, despite teaching the different parts of the brain and making models of brains, the information failed to stick.

This is not an uncommon issue in primary school. All too often, we are guilty of expecting children to learn without really thinking about how this happens.

I first started thinking about this after overhearing a colleague speaking to a pupil about the fact that he had forgotten what they had studied the day before.

Why did that pupil forget what he did yesterday? What is happening in his brain so that he cannot recall that information when others can? That is when I started reading about neural pathways.

Put simply, neural pathways are connections between neurons in the brain, sending messages so that our body knows what to do when completing a task. They are also an excellent way of representing the learning process visually for students of all ages.

The more times we complete a task, the better we become at it because the message has been passed between the neurons more often: the pathways between neurons have become stronger.

I decided I wanted to teach my primary class about this concept to help them truly understand how their brain works and how learning is formed. I turned to technology to help.

We are lucky enough to have access to 10 Sphero robots in our school small plastic spheres that can be programmed or driven manually.

After drawing brains on paper and using blobs of paint for neurons, the pupils were tasked with driving these Spheros between the neurons to create neural pathways.

Using the Sphero Edu app, the children selected the manual drive mode and began trying to control the robots between the blobs of paint. The virtual joystick control is very simple, but the task is surprisingly difficult at first. The more accurate the students became, the more paint they were able to spread between the "neurons".

It was a lot of fun, of course, but my Year 5 students also came to appreciate the fact that the more times they drove between the neurons, the pathways we had created became stronger.

They could also see clearly for themselves how practising something helped them to improve, as their handling of the robots became more controlled the more they practised.

The stronger the pathways on the paper, the stronger the pathways in the learners brain.

The learning process was no longer as abstract to them.

Of course, the robots made this fun but if you dont have the same kind of access to technology, simply drawing lines or using string can also help to make this concept more concrete.

A shared piece of artwork, in which children take it in turns to draw or paint pathways between neurons, can become a useful display piece, which you can keep referring to throughout the year.

Turning the classroom into a brain and having children pass string between each other is another great way to make the concept more visual.

Throughout the year, I am able to refer back to these first-week activities when children are trying something new. It works especially well when pupils are finding something difficult and they are in need of a resilience boost.

Pupils understand more clearly why they are finding something challenging and are more likely to maintain a positive attitude towards their learning.

This strategy has worked equally well on my four-year-old daughter at home. At her age, it is common for children to become frustrated when trying new tasks.

Yet I found that she was very capable of understanding the concept of neural pathways.

Soon she started referring to the pathways herself, be it when she was trying to ride her bike, play tennis, read a new word or complete an addition problem.

If she is becoming stressed or frustrated, reminding her of the fact that she needs to strengthen the neural pathways always helps to calm her down and reassure her that she will be able to be successful with practice.

She is already developing a growth mindset, largely because of this understanding.

Overall, I have found speaking to children about this process and introducing them to metacognition a very effective tool in the classroom, and at home.

There is no reason why we should not be speaking to preschool children about their own learning process, building the foundations for them to become reflective, resilient learners.

And if this means that parents of preschoolers can avoid the odd frustrated tantrum along the way, all the better.

Luke Edeson is a primary teacher at HELPInternational School, Kuala Lumpur, Malaysia. He has taught internationally for 13 years

Visit link:
How I taught neuroscience to primary pupils - and why - TES News

Global Alzheimer’s Platform Foundation Selects IXICO for Innovative Bio-Hermes Trial – PRNewswire

LONDON, Sept. 21, 2020 /PRNewswire/ -- IXICO plc, the data analytics company delivering insights in neuroscience, today announced that it has been selected by the Global Alzheimer's Platform Foundation (GAP) to support GAP's planned Bio-Hermes trial. IXICO will apply its expertise to collect Positron Emission Tomography (PET) brain scans in qualifying imaging centres participating in Bio-Hermes and provide analysis of the scans.

Bio-Hermes' core purpose is development of a bio-sample database to investigate biomarkers on a head-to-head basis in conjunction with medical history elements. The Bio-Hermes trial will include 1,000 volunteers over the age of 60 screened for Preclinical Alzheimer's Disease, Prodromal AD, or Mild Dementia AD. Observational biomarker studies consistently suggest that amyloid deposition and tau deposition in neurofibrillary tangles in the brain may be the sentinel events in Alzheimer's Disease pathology. In the Bio-Hermes trial, Avid Pharmaceuticals' Amyvid will be used as the radioactive diagnostic agent to estimate -amyloid neuritic plaque density.

Giulio Cerroni, Chief Executive Officer of IXICO, commented:

"We are delighted to be selected by GAP as their prime choice for the analysis of PET scans in the Bio-Hermes trial. With a reinvigorated level of interest in Alzheimer's disease, we are excited about the prospects of long-term collaborationwith our colleagues at GAP who share our own commitment to reducing the time, cost, and risk for Alzheimer's Disease trials. The support provided by IXICO staff on Bio-Hermes is an important commercial development in enhancing IXICO's market position in neuroimaging for Alzheimer's Disease clinical trials."

John Dwyer, President of Global Alzheimer's Platform Foundation (GAP), commented:

"Our collaboration with IXICO for neuroimaging and AI is a key element of GAP's innovative Bio-Hermes trial, which is taking a novel approach to provide digital and blood biomarker results for comparison across cognitively normal and impaired individuals. We've also committed to ground-breaking levels of minority participation so that future treatment breakthroughs can benefit everyone impacted by Alzheimer's."

For further information please contact:

IXICO plc Giulio Cerroni, Chief Executive Officer Grant Nash, Chief Financial Officer +44 (0)20 3763 7498

Global Alzheimer's Platform Foundation Media Pamela Larkin +1408-466-5952 or [emailprotected]

About the Global Alzheimer's Platform Foundation (GAP)

The Global Alzheimer's Platform Foundation (GAP) is a patient-centric nonprofit dedicated toacceleratingthe delivery of innovative therapies for neurological disorders by reducing thedurationand cost of clinical trials. Research centersacross the US and Canadaare part of the growing GAP Network (GAP-Net). GAP supportsGAP-Net research centers by assisting withstudy start up and recruitment activities,promotingdiversity in research studies, andofferingnational programsthatchampion brain health and the citizen scientists who make research possible.

About IXICO

IXICO is dedicated to delivering insights in neuroscience. Our purpose is to advance medicine and human health by turning data into clinically meaningful information, providing valuable new insights in neuroscience and our goal is to be a leading proponent of artificial intelligence in medical image analysis. We will achieve this by developing and deploying breakthrough data analytics, at scale, through our remote access technology platform, to improve the return on investment in drug development and reduce risk and uncertainty in clinical trials for our pharmaceutical clients.

More information is available on http://www.IXICO.com.

SOURCE IXICO

https://ixico.com

See the original post:
Global Alzheimer's Platform Foundation Selects IXICO for Innovative Bio-Hermes Trial - PRNewswire

Unearthed concepts revealed at TEDxBinghamtonUniversity – Pipe Dream – Binghamton University Pipe Dream

After its cancellation in March due to the coronavirus pandemic, TEDx BinghamtonUniversity was postponed to this Sunday. In the YouTube Live event, seven speakers unearthed underlying ideas which are often glanced over.

Speakers included a litigator who represented 9/11 ground zero first responders, a geophysicist researching landslides in space, an e-commerce businessman and others. The 10th-annual TEDxBinghamtonUniversity conference was converted to a livestreamed, newscast-style conference this year. Although audience members could not congregate in the Anderson Center as they have in the past, the event has had 520 views on YouTube since Sunday night.

UNEARTHED, the theme of this years talks, was chosen by five student directors. Sofia Fasullo, a student director and junior double majoring in geography and mathematics, said the theme was important in bringing light to concepts which are often left in the dark.

TEDxBinghamtonUniversity UNEARTHED seeks to unearth new ideas, to share those ideas which lie below the surface of our everyday lives and conversations, Fasullo said. Whether it an entirely new and emerging network like cryptocurrency or very slightly different angle on memories that present themselves in an entirely new light whether these buried ideas are unearthed with a shovel or a brush they are worth spreading and that is why we brought our speakers to share them on the Binghamton University stage today.

David Mathews, student speaker at TEDxBinghamtonUniversity 2020 and a junior double-majoring in integrative neuroscience and philosophy, and Flynn Anderson, host of TEDxBinghamtonUniversity 2020 and a junior majoring in biomedical engineering, took to the Osterhout Concert Theater stage with 50 socially distanced attendees in the audience. Anderson acknowledged that this years online format was not ideal, but could still impart something meaningful on each of our lives.

I ask that you guys treat this more of like a Netflix special and less of like an online homework or discussion or something like that, Anderson said. These speakers have been waiting four, five months to give a glimpse into their lives so I ask that you all pay attention because you really never know how someone can change your life.

This years TEDxBinghamtonUniversity lineup included individuals like psychotherapist Laura A. Jacobs, teacher and volunteer Lissarette Nisnevich and comedian Abby Govindan. Each shared a passion for making a mark on the world and spreading their knowledge. Mika McKinnon, a geophysicist who specializes in natural disasters, discussed the relevance of rocks in our past and future and how these hidden gems can be enjoyed by anyone in her talk, Do You Have A Rock?

Every rock has a story, McKinnon said. Rocks are relentless time keepers, tracking everything from ice ages, to magnetic field orientation, to how fast a river flowed.

Max Kurant, a junior majoring in sociology, applied McKinnons speech to a broader context.

This is so interesting, Kurant said. McKinnon really made me wonder if there is an equivalent of rocks in social sciences a simple thing to look at that shows us a story of human social history and predicts the future.

Russell Korus, co-founder and chief executive officer of EZ365, discussed the world of cryptocurrency and how it will be mass incorporated in our future in, Bambi and Godzilla: How Blockchain Turns You From One into the Other.

Throughout the history of fiat currency, we have been Bambi, and the central banks and government have been Godzilla, Korus said. This is the reason I love this stuff so much. Because with cryptocurrencies, we are Godzilla.

Anderson left advice for those who watched the conference.

If theres one thing to take away from this, its to be open-minded and to be open to new ideas, Anderson said.

Students can watch the entire TEDx conference on YouTube.

Check out Pipe Dreams profiles on this years TEDxBinghamtonUniversity speakers:

David Matthews, a Binghamton University junior double-majoring in integrative neuroscience and philosophy

Mika McKinnon, a geophysicist, science writer and sci-fi adviser

Russell Korus, co-founder and chief executive officer of EZ365

Lissarette Nisnevich, early childhood professional in English as a second language (ESL)

Bill Groner, chief executive officer of Settlement Services Arbitration and Mediation who worked on ground zero litigation

Laura A. Jacobs, a transgender and genderqueer psychotherapist, activist, public speaker and author

Abby Govindan, a rising comedian

Read more here:
Unearthed concepts revealed at TEDxBinghamtonUniversity - Pipe Dream - Binghamton University Pipe Dream

‘The Big Bang Theory’: Mayim Bialik Raked in $500k Per Episode – Showbiz Cheat Sheet

Jim Parsons did such a good job playing the nerdy scientist Sheldon Cooper onThe Big Bang Theorythat fans were surprised to learn hes not like his TV personality at all. Parsons isnt that into science, and he doesnt even watchStar Trek.The actor is a typical creative type. Aside from his work onThe Big Bang Theory,hes also starred in Broadway musicals. But there is one actor onThe Big Bang Theory who is a lot like her on-screen character. Mayim Bialik is a scientist in real life, with the credentials to prove it.

Actor Mayim Bialik, who plays Sheldons love interest Amy, doesnt just play a scientist on TV. Like her character, Bialik is a scientist in real life. Amy worked as a neurobiologist onThe Big Bang Theory,and Bialik really does have a Ph.D. in Neuroscience. She graduated from UCLA in 2007 and joined the show in season three, two years later.

Bialik is no stranger to being on camera. She was on the hit showBlossomin the 1990s. When the show ended, she decided she would take a break from acting and go to college. She rose through the ranks and eventually got to the Ph.D. level at UCLA. Interestingly, although the character Amy doesnt appear on the show until season three, the gang makes mention of Bialik herself in the first season. According to IMDb, Raj makes a joke about Bialik, the smart actor fromBlossom, replacing Sheldon on their physics team.

RELATED: The Big Bang Theory: Penny Was Way Meaner in the Original Pilot

Although Bialik has a degree in neuroscience, she doesnt need to work in the field to make money.The Big Bang Theorypaid her a lot of money per episode, and shes raking it in from residuals, even though the show has ended. Warner Brothers supposedly makes $1 billion from re-runs on the still-popular show, and the actors all get a percentage of that. Although Bialik probably doesnt get as big a percentage as the main actors in the show, the residuals fromThe Big Bang Theorywill be a source of income for her for years to come.

Bialik didnt earn the highest salary onThe Big Bang Theory.Although shes an important character, she didnt appear in every episode. She also appeared later in the show than the rest of Sheldons gang, who were all present on day one. Still, by the end of the show, Bialik was earning a cool half million for every episode she filmed forThe Big Bang Theory.

Bialik has a long history in television. Although shes most famous forThe Big Bang TheoryandBlossom,she actually had quite a few TV roles before she played Blossom in the 1990s.

Bialik had roles in classics like The Facts of Life, Murphy Brown, Doogie Howser M.D., The Wonder Years,andWebster.Although she had mostly one or two episode arcs on those shows, her resume reads like a list of the most popular shows of the 1980s. Add her early acting dough with herBlossomandBig Bang Theorymoney, and Bialik has a sizeable net worth of $25 million.

Bialik was able to go to college and get her Ph.D. thanks to the money she made while acting. Its likely that if she had continued working and hadnt spent the cash on a degree, Bialik might have a higher net worth. But without her Ph.D. in neuroscience, she may have never landed the role of Amy. Plus, she wouldnt have been able to pull it off as well as she does.

View original post here:
'The Big Bang Theory': Mayim Bialik Raked in $500k Per Episode - Showbiz Cheat Sheet

Brain-scanning backpack brings neuroscience into the real world – Science Magazine

The mobile brain-monitoring device includes a wand and backpack that works in conjunction with a neural implant. It can also be paired with virtual reality goggles.

By Rebekah TuchschererSep. 18, 2020 , 2:40 PM

Call it neuroscience on the go. Scientists have developed a backpack that tracks and stimulates brain activity as people go about their daily lives. The advance could allow researchers to get a sense of how the brain works outside of a laboratoryand how to monitor diseases such as Parkinsons and post-traumatic stress disorder in real-world settings.

The technology is an inspiring demonstration of whats possible with portable neuroscience equipment, says Timothy Spellman, a neurobiologist at Weill Cornell Medicine who was not involved with the work. The backpack and its vast suite of tools, he says, could broaden the landscape for neuroscience research to study the brain while the body is in motion.

Typically, when scientists want to scan the brain, they need a lot of roomand a lot of money. Functional magnetic resonance imaging (fMRI) scanners, which detect activity in various regions of the brain, are about the size of a pickup truckand can costmore than $1 million. And patients must stay still in the machine for about 1 hour to ensure a clear, readable scan.

Approaches like transcranial magnetic stimulation (TMS) that zap the brainoften to treat severe depressionare also not portable; patients must sit still and upright in a lab for about 30 minutes while a large coil delivers magnetic pulses through their scalp to electrically activate neurons.

Searching for a better way, researchers at the University of California, Los Angeles (UCLA), have developed what they call the mobile deep brain recording and stimulation platform.

Heres how it works: A wand snakes up out of a 9-pound backpack to rest near the top of the patients scalp. There, the wand can communicate with a neural implant that lies deep in the brain. Meanwhile, the backpack is filled with monitorsa setup that allows for real-time data collection from the implant. At the same time, depending on the experiment, the participant can wear additional gear for measuring brain and body activities, including a scalp electroencephalography cap with electrodes that monitor surface brain activity, a pair of virtual reality goggles that track eye movement, and other devices that track heart and breathing rates. All of this information can then be synchronized with signals from the implant.

The beauty of this is that you have many streams of data that are coming in simultaneously, says study author Zahra Aghajan, a UCLA neurophysicist.

In lab testing, the team was able to show that the backpack records activity and stimulates various brain regions without requiring people to stay still. It was also able to collect the same data as an fMRI machine and stimulate the brain in a way similar to TMS, the team reports this week in Neuron.

Not being tied to a lab setting could enable scientists to study how the brain functions while people are in motion and interacting with others, rather than lying still inside an fMRI machine, the researchers say.

Theres a catch, however: Only patients who have neural implants can use the device. About 150,000 people worldwide have such implants, which doctors use to treat and monitor a wide range of conditions including Parkinsons disease, epilepsy, and obsessive-compulsive disorder.

The team has released the backpacks software and blueprints for all scientists to use, says study author Uros Topalovic, a Ph.D. student at UCLA. The hope, he says, is that other researchers can use the technology to study neurological conditions of all kinds without the constraints of a lab or hospital bed.

Read the rest here:
Brain-scanning backpack brings neuroscience into the real world - Science Magazine

Live Imaging Method Links Functional Brain Maps to Structure – Technology Networks

To understand the massive capabilities and complexities of the brain, neuroscientists segment it into regions based on what they appear to do--like processing what we sense or how to move. What's been lacking, however, is an ability to tie those functional maps precisely and consistently to matching distinctions of physical structure, especially in live animals while they are performing the functions of interest. In a new study, MIT researchers demonstrate a new way to do that, providing an unprecedented pairing of functional mapping in live mice with distinguishing structural information for each region all the way through the cortex into deeper tissue below.

"Our study shows for the first time that structural and functional coupling of visual areas in the mouse brain can be detected at sub-cellular resolution in vivo," wrote the authors based in the lab of Mriganka Sur, Newton Professor of Neuroscience in The Picower Institute for Learning and Memory and the Department of Brain and Cognitive Sciences at MIT.

The technique could give scientists more precise ways to distinguish the borders and contents of regions they wish to study and could help them better understand the way that structural distinctions develop within individuals in different functional regions over time. Sur's lab, for instance, is intensely interested in understanding the especially complex development of vision. Humans have 35 or so distinct functional regions that contribute to processing vision, Sur notes, and even mice have 10.

A fly-through of six functionally defined regions of the mouse cortex shows different structures of blood vessels and myelin fibers. These help to produce a distinct optical value for each region called effective attenuation length. Credit:Sur Lab/MIT Picower Institute

In retinotopic mapping, researchers can identify functional regions by engineering neurons to flash when they become electrically active (and show changes in calcium) in response to a particular stimulation. For example, scientists could show a mouse a pattern moving across a screen and mark where neurons light up, with each area showing a characteristic location and pattern of response.

Three-photon microscopy can finely resolve individual cells and their smaller substructures as deep as a millimeter or more--enough to see all the way through the cortex. THG, meanwhile, adds the capability to finely resolve both blood vessels and the fibers of a material called myelin that wrap the long, tendrilous axons of many neurons. THG does not require adding any labeling dyes or chemicals.

Crucially, THG yields an important optical measure called effective attenuation length (EAL), which is a measure of how much the light is absorbed or scattered as it moves through the tissue. In the study, Yildirim and co-authors show that EAL specifically depends on each region's unique architecture of cells, blood vessels and myelin. They measured EAL in each of six visual functional regions and showed that the EAL significantly differed among neighboring visual areas, providing a structural signature of sorts for each functional area. Their measurements were so precise, in fact, that they could show how EAL varied within functional regions, being most unique toward the middle and blending closer to the values of neighboring regions out toward the borders.

In other words, by combining the retinotopic mapping with THG three-photon microscopy, Yildirim said, scientists can identify distinct regions by both their function and structure while continuing to work with animals in live experiments. This can produce more accurate and faster results than making observations during behavior and then dissecting tissue in hopes of relocating those same exact positions in preserved brain sections later.

"We would like to combine the strength of retinotopic mapping with three-photon imaging to get more structural information," Yildirim said. "Otherwise there may be some discrepancies when you do the live imaging of brain activity but then take the tissue out, stain it and try to find the same region."

Especially as three-photon microscopy gains wider adoption and imaging speeds improve--right now imaging a millimeter deep column of cortex takes about 15 minutes, the authors acknowledge--the team expects its new method could be used not only for studies of the visual system but also in regions all around the cortex. Moreover it may help characterize disease states as well as healthy brain structure and function.

"This advance should enable similar studies of structural and functional coupling in other sensory and non-sensory cortical areas in the brains of mice and other animal models," they wrote. "We believe that the structural and functional correlation in visual areas that we describe for the first time points to crucial developmental mechanisms that set up these areas, thus our work would lead to a better fundamental understanding of brain development, and of disorders such as Alzheimer's, stroke and aging."Reference:

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Here is the original post:
Live Imaging Method Links Functional Brain Maps to Structure - Technology Networks

NEUROSCIENCE ANTIBODIES AND ASSAYS Market to Witness Exponential Growth by 2020-2027 | Leading Players Thermo Fisher Scientific Inc. , Overview,…

Fort Collins, Colorado The report on the NEUROSCIENCE ANTIBODIES AND ASSAYS Market provides an in-depth assessment of the NEUROSCIENCE ANTIBODIES AND ASSAYS market including technological advancements, market drivers, challenges, current and emerging trends, opportunities, threats, risks, strategic developments, product advancements, and other key features. The report covers market size estimation, share, growth rate, global position, and regional analysis of the market. The report also covers forecast estimations for investments in the NEUROSCIENCE ANTIBODIES AND ASSAYS industry from 2020 to 2027.

The report is furnished with the latest market dynamics and economic scenario in regards to the COVID-19 pandemic. The pandemic has brought about drastic changes in the economy of the world and has affected several key segments and growth opportunities. The report provides an in-depth impact analysis of the pandemic on the market to better understand the latest changes in the market and gain a futuristic outlook on a post-COVID-19 scenario.

Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market to reach USD 5.1 billion by 2025. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market valued approximately USD 2.1 billion in 2016 is anticipated to grow with a healthy growth rate of more than 10.3% over the forecast period 2017-2025.

Get a sample of the report @ https://reportsglobe.com/download-sample/?rid=4794

The report provides an in-depth analysis of the key developments and innovations of the market, such as research and development advancements, product launches, mergers & acquisitions, joint ventures, partnerships, government deals, and collaborations. The report provides a comprehensive overview of the regional growth of each market player.

Additionally, the report provides details about the revenue estimation, financial standings, capacity, import/export, supply and demand ratio, production and consumption trends, CAGR, market share, market growth dynamics, and market segmentation analysis.

The report covers extensive analysis of the key market players in the market, along with their business overview, expansion plans, and strategies. The key players studied in the report include:

Furthermore, the report utilizes advanced analytical tools such as SWOT analysis and Porters Five Forces Analysis to analyze key industry players and their market scope. The report also provides feasibility analysis and investment return analysis. It also provides strategic recommendations to formulate investment strategies and provides insights for new entrants.

Request a discount on the report @ https://reportsglobe.com/ask-for-discount/?rid=4794

The report is designed with an aim to assist the reader in taking beneficial data and making fruitful decisions to accelerate their businesses. The report provides an examination of the economic scenario, along with benefits, limitations, supply, production, demands, and development rate of the market.

By Product :

By Technology:

By End User:

Request customization of the report @https://reportsglobe.com/need-customization/?rid=4794

Regional Analysis of the Market:

For a better understanding of the global NEUROSCIENCE ANTIBODIES AND ASSAYS market dynamics, a regional analysis of the market across key geographical areas is offered in the report. The market is spread acrossNorth America, Europe, Latin America, Asia-Pacific, and Middle East & Africa.Each region is analyzed on the basis of the market scenario in the major countries of the regions to provide a deeper understanding of the market.

Benefits of the Global NEUROSCIENCE ANTIBODIES AND ASSAYS Report:

To learn more about the report, visit @ https://reportsglobe.com/product/global-neuroscience-antibodies-and-assays-market-size-study/

Thank you for reading our report. To learn more about report details or for customization information, please contact us. Our team will ensure that the report is customized according to your requirements.

How Reports Globe is different than other Market Research Providers

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390

Email:[emailprotected]

Web:reportsglobe.com

Visit link:
NEUROSCIENCE ANTIBODIES AND ASSAYS Market to Witness Exponential Growth by 2020-2027 | Leading Players Thermo Fisher Scientific Inc. , Overview,...

How Fear Persists in the Mouse Brain – ScienceBlog.com

Most people have experienced, at some point in their lives, a sudden unexpected fright. Even after a shadowy figure in a darkened room turns out to just be a chair, your heart rate is still high, your palms stay sweaty, and your senses remain alert for another threat. This sort of lasting response is an example of a persistent internal state. The phenomenon of persistence is what distinguishes an internal emotional state from a reflex, such as jumping when hearing a loud noise.

In a similar way, mice exhibit fear responses to threats, such as the presence of a rat, and these behaviors appear to linger even after the threat is gone. What is happening in the mouse brain at the cellular level during these persistent displays of fear behavior? A team of neuroscientists in the Caltech laboratory ofDavid AndersonSeymour Benzer Professor of Biology, Tianqiao and Chrissy Chen Institute for Neuroscience Leadership Chair, Howard Hughes Medical Institute Investigator, and director of theTianqiao and Chrissy Chen Institute for Neuroscienceanswer this question in a new paper appearing in the journalNatureon September 16.

An interdisciplinary team effort led by former postdoctoral scholar Ann Kennedy, former Caltech staff scientist Prabhat Kunwar, and postdoctoral scholar Ling-yun Li has discovered the neural mechanisms underlying persistent fear responses. Surprisingly, the team discovered that these persistent responses are encoded in a center of the brain that was thought to be much more evolutionarily primitive and reflexive.

The overarching significance of our findings is that they show that persistent fear states are not due simply to persistently elevated stress hormones, as traditionally thought, but also involve persistent electrical activity in the brain, says Anderson. It is surprising to find such neural dynamics in the hypothalamusa fundamental region of the brain found in all vertebrates including humanssince this type of persistent activity is more often associated with cognitive functions, such as working memory, in the cortex.

Mice have a well-characterized repertoire of defensive behaviors, such as freezing and fleeing. In the study, the team focused on a particular facet of mices fear response to rats: when a rat is present in a mouses experimental arena, the mouse will hug up against the walls of the space instead of roaming freely around.

In their study, the researchers specifically focused on a brain region called the ventromedial hypothalamus (VMH). In 2015, researchers from the Anderson lab discovered that the VMH encodes for defensive behaviors in mice.

The hypothalamus is generally thought by neuroscientists to be a primitive area, controlling reflexes in a robotic way. Neurons receive a stimulus, react accordingly, and shut off again, says Kennedy, who is now a professor of physiology at Northwestern University. Our work shows that this is not always the case.

In this new research, the team found that VMH neurons are activated when presented with a threatthe nearby ratand that they stay active for tens of seconds even after the rat is taken away. In general, neurons are usually only active for a few milliseconds. The team also found that they could induce mice to display fear behaviors by artificially stimulating these neurons, and essentially make mice unafraid by artificially silencing them.

Because the lingering fear response might be due to some lingering rat odor, the researchers examined mices fear response when they were presented with only sounds at the precise frequency at which rats vocalize. In this case, the mice also displayed persistent fear behavior and their VMH neurons were persistently active, again for tens of seconds, after the sound ceased.

The team then took a closer look at the activity of individual neurons in the VMH, instead of just the overall activity of the area. This would be like examining the individual activity of each musician in an orchestra, instead of listening to the whole orchestra playing together. Measuring individual neuron activity showed that there were two distinct populations of neurons that each responded to the two different types of threatsrat sound versus rat presence.

How did the persistent neural activity last for tens of seconds, when neurons only fire in bursts of activity on the order of milliseconds? Two possible mechanisms might explain this. First, the neurons may form a so-called neural feedback loop that causes their sequential activation, like runners passing a baton during a relay; or second, the neurons may release chemicals into their environment that keep triggering their re-activation. Alternatively, a combination of both scenariosa neural feedback loop and the release of neurochemicalsmight be at play.

Kennedy developed neural networks to model the first scenario, the second scenario, and combinations of the two to find out which would accurately predict the persistent neural activity following a stimulus as well as the identity of the stimulus (i.e., the actual presence of a rat or only the sound of a rat). Only the combination models could explain both of these features.

The paper is titledStimulus-specific hypothalamic encoding of a persistent defensive state.Kennedy, Kunwar, and Li are the studys first authors. Postdoctoral scholar Stefanos Stagkourakis, Research Professor of Biology and Biological Engineering Daniel Wagenaar (PhD 06), and Anderson are co-authors. Funding was provided by the National Institutes of Health, the Simons Collaboration on the Global Brain Foundation, the Helen Hay Whitney Foundation, and the EMBO ALTF.

Originally posted here:
How Fear Persists in the Mouse Brain - ScienceBlog.com

Backed by $1.1 million grant, UNR Med researcher studying root of Alzheimer’s, Parkinson’s diseases – Northern Nevada Business Weekly

RENO, Nev. Every person carries around a 3-pound universe filled with billions of cells that communicate and orchestrate everything we do from thinking to moving to sensing.

It makes sense that such a busy planet of activity can get stressed or damaged as we age.

For some, this can potentially lead to neurodegenerative diseases of the brain, such as Alzheimers, a type of dementia that slowly destroys memory skills, thinking skills and, eventually, the ability to carry out daily activities.

In 2018, Nevada saw 874 people die from Alzheimers disease, making it the sixth-leading cause of death in the state, according to the Alzheimers Association. All told, that year the total number of Nevadans aged 65 and older with Alzheimers was 45,000, a number projected to jump to 64,000 by 2025.

Yet, despite decades of neuroscience research, scientists dont yet fully understand what causes neurodegenerative diseases of the brain like Alzheimers and Parkinsons and how to treat them.

One researcher at the University of Nevada, Reno School of Medicine, with the help of a federal grant, is on a mission to help change that.

Dr. Robert Renden, assistantprofessor in the department of physiology and cell biology at UNR Med and the UNR Neuroscience Institute, this summer was awarded a five-year, $1.1 million grant from the National Science Foundation (NSF).

Specifically, Renden will explore how brain cells maintain the energy needed to communicate at contact sites synapses which play a critical role in a variety of cognitive processes, learning and memory. Moreover, synapses play a crucial role in many brain diseases and disorders.

This project answers the NSF mission of really understanding the most basic biology of how synapses function, Renden said in a video interview with Peak NV. And also provide a component to help educate the next generation of researchers, which is part of the NSF mission. This will help UNR Med by providing research opportunities for med school students, physician assistants, postdocs thats the immediate payoff.

The longer-term payoff will be having the basic knowledge of how these synapses function. And then that will inform us what could probably be going wrong when we have disease states.

To that end, Renden said that his study aims to advance new approaches in the study of Alzheimers, Parkinsons and dementia, among others. Theseneurodegenerativediseases, he said, result from a loss of energy production, homeostasis and reduced mitochondria function.

That delivery of energy and utilization of energy is fundamentally and acutely important, Renden said. One of the goals of this research is to try to tie that together at a really fundamental level. And so the hope is that we can make really basic observations about how energy is utilized, generated and distributed at synapses.

Renden is collaborating with Dr. Ruben Dagda, associate professor in pharmacology at UNR Med, who is looking at brain disease models. Dagda said Alzheimers research is lagging behind severely in Nevada due to a lack of state funding, making Rendens research grant all the more important.

Our hope is that whatever we publish, our observations can lead us to a better understanding ofAlzheimers, Dagda told Peak NV. Its very important because in Nevada, 15% of its population is over 65. And by 2025, its going to be over 20%.

And people over 65 have a two-fold increase or 200% for developing Alzheimers, according to Dagda. In addition, they have an 80% increase in developing Parkinsons, he added.

Why?Dagdacontinued. We dont really know but the destructionand energy production and the utilization of energy and the brain makes the neurons very sensitive to dying. We know in those two diseases, theres an increase in stress and inflammation in the brain.

With that in mind, Renden said if research can lead to identifying the potential for these neurodegenerative problems early before clinical symptoms surface they could then be treated early with self-care, proper nutrition and exercise.

After all, Parkinsons and Alzheimers symptoms do now show up until significant damage in the brain has already been done, according to Renden.

You dont see Parkinsons disease motor symptoms until something like 80% of your dopaminergic neurons are dead, he explained. And for Alzheimers disease, youve got to see profound structural loss literally chunks of the brain dying off before you see the clinical manifestation.

Simply put, Renden and Dagda are using techniques to identify changes in synaptic function or cellular function far in advance of cellular death.

In the (petri) dish, we can see the cells as theyre starting to get stressed or just starting to get damaged, Renden said. And then the idea is that at that point youd want to go in and do some of these really early, noninvasive nutritional-type interventions, which have been shown to be really effective.

Go to unr.edu/neuroscience to learn more about the Institute for Neuroscience at the University of Nevada, Reno.

Visit link:
Backed by $1.1 million grant, UNR Med researcher studying root of Alzheimer's, Parkinson's diseases - Northern Nevada Business Weekly

Yale teams get multi-million-dollar awards to study biology of Parkinson’s – Yale News

Two Yale research teams will each receive approximately $9 million in grants from the Aligning Sciences Across Parkinsons (ASAP) initiative to study the underlying biology of Parkinsons disease.

The ASAP grants, to be distributed over three years, are part of a major international, multi-institutional effort to uncover the basic disease mechanisms that drive the progressive neurological disorder, which afflicts 7 to 10 million people worldwide. The initiative builds and leverages a network of leading investigators, which will ultimately serve to promote rapid access to data, enabling breakthroughs across scales that will accelerate benefits for patients.

A Yale team headed byPietro De Camilli, the John Klingenstein Professor of Neuroscience, professor of cell biology, and investigator for the Howard Hughes Medical Institute, will study how gene mutations linked to Parkinsons affect the function of brain cells during the course of the disease. De Camilli will team with scientists from Weill Cornell Medicine to study the impact of Parkinsons disease on the physiology and metabolism of synapses, with the goal of identifying new therapeutic targets.

A second Yale team led byDavid Hafler, the William S. and Lois Stiles Edgerly Professor of Neurology and professor of immunobiology, will investigate whether the progression of Parkinsons disease pathology in the brain is initiated by an autoimmune process triggered by the gut microbiome. The research, part of the Center for Neuroinflammation at Yale, will leverage long-standing collaborations with researchers from Massachusetts General Hospital and the Broad Institute to produce an unprecedented map of the neuro-immune-gut interactions, with the goal of identifying new treatments for the disease.

The awards to two Yale teams illustrate the universitys dedication to collaborative science and the growing role Yale neuroscientists are playing in elucidating fundamental mechanisms of the most intractable conditions afflicting the brain and central nervous system, said Nancy J. Brown, dean of the Yale School of Medicine. Without a more robust understanding of basic mechanisms we cannot make progress in the treatment of Parkinsonism, she added.

Other Yale members of the De Camilli team areKarin Reinisch, the David W. Wallace Professor of Cell Biology and of molecular biophysics and biochemistry;Shawn Ferguson, associate professor of cell biology and neuroscience; andKallol Gupta, assistant professor of cell biology.

Other Yale members of the Hafler team areLe Zhang, assistant professor of neurology;Sreeganga Chandra,associate professor of neurology and neuroscience;Rui Chang,assistant professor of neuroscience;Noah Palm,assistant professor of immunobiology;Brian KooandJesse Cedarbaum, members of the clinical Department of Neurology; andDavid van Dijk, assistant professor in the Department of Medicine and Genetics.

ASAP is a coordinated research initiative dedicated to fostering collaboration and resources to better understand the underlying causes of Parkinsons disease. The Michael J. Fox Foundation is ASAPs implementation partner and issued the grants.

Continued here:
Yale teams get multi-million-dollar awards to study biology of Parkinson's - Yale News